Sunwook Kim, MD
Obstetrics & Gynecology · Las Vegas, NVNPI 1255474359
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,945 of the $94,231 with a category attached, or 63.6%. Applied Medical Resources Corporation accounts for 83.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $42,716 and has fallen 52.6% since, to $20,260 in 2025. Among obstetrics & gynecology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $471.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$79K
- Virtual Incision Corporation$8K
- Intuitive Surgical$4K
- Hologic Sales And Service, LLC$815
- AbbVie$612
- Arthrex$273
- plus $2K from 23 others
What the payments were for
- Consulting fees$9,57510%
- Speaking & faculty fees$59,94564%
- Travel & lodging$16,99918%
- Food & beverage$6,0306%
- Education$1,6822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 115 | $78,953 |
| Virtual Incision Corporation | 1 | $8,000 |
| Intuitive Surgical | 17 | $4,060 |
| Hologic Sales And Service, LLC | 18 | $815 |
| AbbVie | 12 | $612 |
| Arthrex | 2 | $273 |
| Astellas Pharma US Inc | 4 | $212 |
| Momentis Surgical Inc. | 1 | $179 |
| LSI Solutions Inc | 2 | $152 |
| Coloplast | 1 | $142 |
| Biogen | 1 | $125 |
| Sumitomo Pharma America, Inc. | 2 | $123 |
| Coopersurgical, Inc. | 1 | $100 |
| Exact Sciences | 3 | $63 |
| Medtronic | 1 | $54 |
| Mayne Pharma Commercial LLC | 2 | $53 |
| Exeltis, USA Inc. | 2 | $44 |
| Pfizer | 2 | $38 |
| Lupin Inc. | 2 | $27 |
| Allotrope Medical, Inc | 1 | $27 |
| Organon | 2 | $27 |
| Bayer | 1 | $25 |
| Inari Medical, Inc. | 1 | $25 |
| Medical Device Business Services, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $18 |
| Minerva Surgical, Inc | 1 | $18 |
| Abbott | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$69,086
- Mira!$8,000
- Da Vinci Surgical System$3,756
- GelPOINT Path Transanal Access Platform$3,000
- ACESSA PROVU SYSTEM$248
- Orilissa$233
- Hominis Surgical System$179
- ARTHREX$147
- ALTIS$142
- Zurzuvae$125
- ORIAHNN$123
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$119
- MYOSURE TISSUE REMOVAL DEVICE$103
- NovaSure$103
- MYFEMBREE$102
- Veozah$101
- Uterine Manipulators & Injectors$100
How this compares
$94,231 in reported general payments places this provider in the 95th percentile of 308 obstetrics & gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 23 | $10,893 |
| VeozahFezolinetant | 14 | $7,913 |
| Estradiol | 38 | $1,747 |
| Clobetasol Propionate | 15 | $214 |
| Acyclovir | 12 | $146 |
| Alendronate Sodium | 17 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $38 | $10,89323 claims |
| Astellas Pharma US IncVeozah | $212 | $7,91314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 308 obstetrics & gynecology providers in Nevada.
Other obstetrics & gynecology in Las Vegas
- Darin SwainstonLas Vegas$713K
- Christina KushnirLas Vegas$502K
- Lamarr TylerLas Vegas$170K
- Ralph VennartLas Vegas$144K
- Kenneth VolkerLas Vegas$126K
- Navkaran SinghLas Vegas$104K
- Luis Lopez BenitezLas Vegas$89K
- Linda TranLas Vegas$72K
- Raul Romero JosephLas Vegas$61K
- Nadia GomezLas Vegas$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.